VAS
Vestmark Advisory Solutions’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-796
| Closed | -$206K | – | 531 |
|
|
2023
Q4 | $206K | Sell |
796
-21
| -3% | -$5.43K | 0.01% | 486 |
|
|
2023
Q3 | $210K | Sell |
817
-6,977
| -90% | -$1.79M | 0.02% | 391 |
|
|
2023
Q2 | $2.22M | Buy |
7,794
+152
| +2% | +$43.3K | 0.08% | 299 |
|
|
2023
Q1 | $2.12M | Buy |
7,642
+51
| +0.7% | +$14.2K | 0.09% | 286 |
|
|
2022
Q4 | $2.1M | Sell |
7,591
-1,085
| -13% | -$300K | 0.1% | 273 |
|
|
2022
Q3 | $2.32M | Buy |
8,676
+205
| +2% | +$54.7K | 0.13% | 223 |
|
|
2022
Q2 | $1.73M | Sell |
8,471
-260
| -3% | -$53K | 0.1% | 266 |
|
|
2022
Q1 | $1.84M | Buy |
8,731
+1,335
| +18% | +$281K | 0.1% | 258 |
|
|
2021
Q4 | $1.77M | Sell |
7,396
-1,328
| -15% | -$319K | 0.1% | 251 |
|
|
2021
Q3 | $2.47M | Buy |
8,724
+54
| +0.6% | +$15.3K | 0.17% | 152 |
|
|
2021
Q2 | $3M | Buy |
8,670
+257
| +3% | +$89K | 0.21% | 117 |
|
|
2021
Q1 | $2.35M | Buy |
8,413
+299
| +4% | +$83.7K | 0.21% | 127 |
|
|
2020
Q4 | $1.99M | Sell |
8,114
-660
| -8% | -$162K | 0.22% | 126 |
|
|
2020
Q3 | $2.49M | Sell |
8,774
-155
| -2% | -$44K | 0.33% | 75 |
|
|
2020
Q2 | $2.39M | Sell |
8,929
-754
| -8% | -$202K | 0.37% | 60 |
|
|
2020
Q1 | $3.06M | Buy |
+9,683
| New | +$3.06M | 0.6% | 33 |
|
|
2019
Q4 | – | Sell |
-10,685
| Closed | -$2.49M | – | 280 |
|
|
2019
Q3 | $2.49M | Sell |
10,685
-316
| -3% | -$73.6K | 0.4% | 60 |
|
|
2019
Q2 | $2.57M | Sell |
11,001
-1,829
| -14% | -$428K | 0.44% | 51 |
|
|
2019
Q1 | $3.03M | Buy |
+12,830
| New | +$3.03M | 0.54% | 32 |
|